Table 1.
Characteristics of the study population
| SN | Characteristic | Cases (n = 50) | Controls (n = 50) | Significance of difference |
|---|---|---|---|---|
| 1. | Mean age ±SD (Range) in years |
55.98 ± 11.00 (28-75) |
53.66 ± 9.88 (31-75) | ‘t’=1.109; p = 0.270 |
| 2. | Gender Male Female |
34 (68.0%) 16 (32.0%) |
40 (80.0%) 10 (20.0%) |
χ2=1.871; p = 0.171 |
| 3. | Mean weight ± SD in kg | 67.85 ± 14.08 | 61.46 ± 6.17 | ‘t’=2.940; p = 0.004 |
| 4. | Mean height ±SD in cm | 161.42 ± 8.81 | 161.92 ± 6.68 | ‘t’=0.320; p = 0.750 |
| 5. | Mean BMI ±SD (range) in kg/m² |
25.90 ± 4.60 (17.88–38.33) |
23.46 ± 2.16 (19.05–31.64) | ‘t’=3.386; p = 0.001 |
| 6. | Duration of illness <5 years 5–10 years >10 years Mean duration ± SD (Range) in years |
23 (46%) 14 (28%) 13 (26%) 7.38 ± 5.97 (1-25) |
|
|
| 7. | Level of glycemic control Good (<7%) Intermediate (7–8.5%) Poor (>8.5%) Mean HbA1c ± SD (Range) in % |
17 (34%) 5 (10%) 28 (56%) 8.42 ± 2.52 (4.4–15.3) |
|
|
| 8. | Drug regimen OHA Insulin |
47 (94%) 3 (6%) |
|
BMI, body mass index; OHA, oral hypoglycemic agent; SD, standard deviation.